Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)
Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX) and Tenet Healthcare (THC)
Analysts Offer Insights on Healthcare Companies: Inmune Bio (INMB), Insmed (INSM) and Tenet Healthcare (THC)
Tenet Healthcare Analyst Ratings
Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $147
Barclays Reaffirms Their Buy Rating on Tenet Healthcare (THC)
Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), GE Healthcare Technologies Inc (GEHC) and Tenet Healthcare (THC)
Tenet Healthcare's Strong Q1 Performance and Upward Guidance Justify Buy Rating
RBC Raises Tenet Healthcare Price Target to $136 From $109, Maintains Outperform Rating
Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $130
Tenet Healthcare Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)
RBC Capital Remains a Buy on Tenet Healthcare (THC)